BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37213190)

  • 21. Evaluating the impact of stay-at-home and quarantine measures on COVID-19 spread.
    Zhang R; Wang Y; Lv Z; Pei S
    BMC Infect Dis; 2022 Jul; 22(1):648. PubMed ID: 35896977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies.
    Coletti P; Libin P; Petrof O; Willem L; Abrams S; Herzog SA; Faes C; Kuylen E; Wambua J; Beutels P; Hens N
    BMC Infect Dis; 2021 May; 21(1):503. PubMed ID: 34053446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustainable targeted interventions to mitigate the COVID-19 pandemic: A big data-driven modeling study in Hong Kong.
    Zhou H; Zhang Q; Cao Z; Huang H; Dajun Zeng D
    Chaos; 2021 Oct; 31(10):101104. PubMed ID: 34717342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The stringency of the containment measures in response to COVID-19 inversely correlates with the overall disease occurrence over the epidemic wave.
    Mezencev R; Klement C
    Bratisl Lek Listy; 2022; 123(9):601-617. PubMed ID: 36039877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early adoption of non-pharmaceutical interventions and COVID-19 mortality.
    Amuedo-Dorantes C; Borra C; Rivera-Garrido N; Sevilla A
    Econ Hum Biol; 2021 Aug; 42():101003. PubMed ID: 33894688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19.
    Bendavid E; Oh C; Bhattacharya J; Ioannidis JPA
    Eur J Clin Invest; 2021 Apr; 51(4):e13484. PubMed ID: 33400268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the impact on COVID-19 mortality of self-imposed behavior change and of government regulations across 13 countries.
    Jamison JC; Bundy D; Jamison DT; Spitz J; Verguet S
    Health Serv Res; 2021 Oct; 56(5):874-884. PubMed ID: 34182593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of influenza-like illness under urbanization procedure and COVID-19 pandemic in the subcenter of Beijing during 2013-2021.
    Wang C; Yang YN; Xi L; Yang LL; Du J; Zhang ZS; Lian XY; Cui Y; Li HJ; Zhang WX; Liu B; Cui F; Lu QB
    J Med Virol; 2022 Aug; 94(8):3801-3810. PubMed ID: 35451054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal adaptive nonpharmaceutical interventions to mitigate the outbreak of respiratory infections following the COVID-19 pandemic: a deep reinforcement learning study in Hong Kong, China.
    Yao Y; Zhou H; Cao Z; Zeng DD; Zhang Q
    J Am Med Inform Assoc; 2023 Aug; 30(9):1543-1551. PubMed ID: 37364025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the effect of social inequalities on the mitigation of COVID-19 across communities in Santiago de Chile.
    Gozzi N; Tizzoni M; Chinazzi M; Ferres L; Vespignani A; Perra N
    Nat Commun; 2021 Apr; 12(1):2429. PubMed ID: 33893279
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human choice to self-isolate in the face of the COVID-19 pandemic: A game dynamic modelling approach.
    Ngonghala CN; Goel P; Kutor D; Bhattacharyya S
    J Theor Biol; 2021 Jul; 521():110692. PubMed ID: 33771612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 pandemic in prisons in Spain: characteristics of cases and implemented control measures, March 2020-June 2022.
    Hernando V; Vázquez I; Díaz A; Gómez-Pintado P; Martínez-Aznar C; Acín E
    Public Health; 2023 May; 218():45-52. PubMed ID: 36965463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unintended Consequences of COVID-19 Non-Pharmaceutical Interventions (NPIs) for Population Health and Health Inequalities.
    ÓhAiseadha C; Quinn GA; Connolly R; Wilson A; Connolly M; Soon W; Hynds P
    Int J Environ Res Public Health; 2023 Mar; 20(7):. PubMed ID: 37047846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonpharmaceutical Interventions Used to Control COVID-19 Reduced Seasonal Influenza Transmission in China.
    Lei H; Xu M; Wang X; Xie Y; Du X; Chen T; Yang L; Wang D; Shu Y
    J Infect Dis; 2020 Nov; 222(11):1780-1783. PubMed ID: 32898256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public Acceptance of Measures to Control Infectious Diseases Under Different Scenarios of Severity and Transmissibility.
    Epstein D; Pérez-Troncoso D; Ruiz-Adame M; Castañeda JA
    Value Health; 2024 May; 27(5):562-569. PubMed ID: 38401797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Cost-Benefit and Measures During the COVID-19 Pandemic for Incoming Travelers Through Tests in Origin in Spain.
    Domínguez C; García R; Sánchez J; Suárez JP; Dávila-Quintana CD
    Front Public Health; 2022; 10():816406. PubMed ID: 35615046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ranking the effectiveness of worldwide COVID-19 government interventions.
    Haug N; Geyrhofer L; Londei A; Dervic E; Desvars-Larrive A; Loreto V; Pinior B; Thurner S; Klimek P
    Nat Hum Behav; 2020 Dec; 4(12):1303-1312. PubMed ID: 33199859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 pandemic spread against countries' non-pharmaceutical interventions responses: a data-mining driven comparative study.
    Xylogiannopoulos KF; Karampelas P; Alhajj R
    BMC Public Health; 2021 Sep; 21(1):1607. PubMed ID: 34470630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the population effectiveness of interventions against COVID-19 in France: A modelling study.
    Ganser I; Buckeridge DL; Heffernan J; Prague M; Thiébaut R
    Epidemics; 2024 Mar; 46():100744. PubMed ID: 38324970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
    Oh KB; Doherty TM; Vetter V; Bonanni P
    Expert Rev Vaccines; 2022 Nov; 21(11):1541-1553. PubMed ID: 36039786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.